Literature DB >> 10946421

Diagnostic testing for hepatitis C.

R L Carithers1, A Marquardt, D R Gretch.   

Abstract

Diagnostic tests for hepatitis C virus have improved dramatically over the past decade. Highly accurate tests are now available for screening patients for possible hepatitis C infections and confirming the presence of active viral infection. HCV RNA levels and genotype are very useful in assessing the likelihood of response to antiviral therapy and in guiding the optimum duration of treatment. Absence of detectable HCV RNA using PCR methodology has become the gold standard of successful treatment of patients with chronic hepatitis C. The various tests for hepatitis C are expensive and have their limitations. However, selective use of these assays has greatly improved the care of patients with chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946421     DOI: 10.1055/s-2000-9939

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  6 in total

1.  Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.

Authors:  Isabelle Desombere; Hans Van Vlierberghe; Sibyl Couvent; Filip Clinckspoor; Geert Leroux-Roels
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 2.  Management of hepatitis C in patients with chronic kidney disease.

Authors:  Roberto J Carvalho-Filho; Ana Cristina C A Feldner; Antonio Eduardo B Silva; Maria Lucia G Ferraz
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

3.  Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA.

Authors:  David A Hendricks; Michel Friesenhahn; Lorine Tanimoto; Bernd Goergen; Deborah Dodge; Lorraine Comanor
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

4.  Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence.

Authors:  Jennifer G Plebani; Carlos F Tirado; Helen M Pettinati; Kyle M Kampman; Joseph R Volpicelli; David W Oslin
Journal:  Addict Behav       Date:  2009-09-10       Impact factor: 3.913

5.  Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia.

Authors:  Yeon Seok Seo; Eun Suk Jung; Jeong Han Kim; Young Kul Jung; Ji Hoon Kim; Hyonggin An; Hyung Joon Yim; Jong Eun Yeon; Kwan Soo Byun; Chang Duck Kim; Ho Sang Ryu; Soon Ho Um
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 3.165

6.  Introduction of an automated system for the diagnosis and quantification of hepatitis B and hepatitis C viruses.

Authors:  Mt Cabezas-Fernandez; Mi Cabeza-Barrera
Journal:  Open Virol J       Date:  2012-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.